+499.5%
MRNA vs OKTA
+90.9%
+408.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | OKTA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.1% | -2.3% | -2.2% |
| 7D | +5.5% | +2.6% | +2.8% | +5.4% |
| 30D | +158.7% | +16.0% | +142.7% | +159.8% |
| 3M | +182.1% | +38.2% | +144.0% | +178.7% |
| 6M | +151.8% | +137.8% | +14.0% | +129.5% |
| YTD | +393.6% | +97.3% | +296.3% | +371.7% |
| 1Y | +499.5% | +90.1% | +409.4% | +480.3% |
| All | +499.5% | +90.9% | +408.6% | +480.3% |
Cumulative growth
Daily Returns
Daily percentage return beside OKTA.
Daily Out/Under-Performance
Portfolio return minus OKTA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × OKTA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded OKTA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling